$BNGO
Bionano Genomics, Inc.

2018 Q4 Form 10-Q Financial Statement

#000156459018028130 Filed on November 07, 2018

View on sec.gov

Income Statement

Concept 2018 Q4 2018 Q3 2017 Q3
Revenue $4.014M $2.829M $2.743M
YoY Change 41.07% 3.12%
Cost Of Revenue $2.988M $3.068M $1.690M
YoY Change 99.72% 81.53%
Gross Profit $1.025M -$239.6K $1.053M
YoY Change -23.98% -122.76%
Gross Profit Margin 25.55% -8.47% 38.38%
Selling, General & Admin $4.600M $3.224M $3.117M
YoY Change 30.31% 3.44%
% of Gross Profit 448.6% 296.05%
Research & Development $2.520M $2.505M $2.967M
YoY Change 2.44% -15.57%
% of Gross Profit 245.75% 281.82%
Depreciation & Amortization $150.0K $391.2K $240.6K
YoY Change -72.22% 62.65%
% of Gross Profit 14.63% 22.85%
Operating Expenses $7.120M $5.729M $6.084M
YoY Change 19.06% -5.83%
Operating Profit -$6.095M -$5.969M -$5.031M
YoY Change 31.6% 18.64%
Interest Expense -$270.0K $404.4K $145.3K
YoY Change 68.75% 178.33%
% of Operating Profit
Other Income/Expense, Net -$40.00K $1.040M -$59.03K
YoY Change -92.31% -1861.48%
Pretax Income -$6.400M -$4.929M -$5.090M
YoY Change 8.11% -3.17%
Income Tax $10.00K -$2.978K -$4.738K
% Of Pretax Income
Net Earnings -$6.411M -$4.926M $5.085M
YoY Change -208.3% -196.87%
Net Earnings / Revenue -159.75% -174.15% 185.39%
Basic Earnings Per Share
Diluted Earnings Per Share -$633.4K -$491.5K -$536.4K
COMMON SHARES
Basic Shares Outstanding 10.03M
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q4 2018 Q3 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $16.50M $20.70M
YoY Change
Cash & Equivalents $16.52M $20.66M $2.634M
Short-Term Investments
Other Short-Term Assets $384.1K $1.099M
YoY Change -30.17%
Inventory $1.069M $2.615M
Prepaid Expenses
Receivables $4.514M $4.001M
Other Receivables $0.00 $0.00
Total Short-Term Assets $23.03M $28.62M
YoY Change 222.51%
LONG-TERM ASSETS
Property, Plant & Equipment $1.777M $2.049M
YoY Change -40.87%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.777M $2.049M
YoY Change -40.87%
TOTAL ASSETS
Total Short-Term Assets $23.03M $28.62M
Total Long-Term Assets $1.777M $2.049M
Total Assets $24.80M $30.67M
YoY Change 144.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.352M $2.364M
YoY Change -41.3%
Accrued Expenses $2.900M $2.815M
YoY Change -17.35%
Deferred Revenue $271.0K
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00
YoY Change -100.0%
Total Short-Term Liabilities $4.523M $5.515M
YoY Change -72.84%
LONG-TERM LIABILITIES
Long-Term Debt $9.029M $9.008M
YoY Change
Other Long-Term Liabilities $808.4K $767.2K
YoY Change 42.56%
Total Long-Term Liabilities $9.838M $9.776M
YoY Change 1634.91%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.523M $5.515M
Total Long-Term Liabilities $9.838M $9.776M
Total Liabilities $14.67M $15.43M
YoY Change -15.53%
SHAREHOLDERS EQUITY
Retained Earnings -$72.76M -$66.35M
YoY Change 34.08%
Common Stock $82.90M $81.59M
YoY Change 1952.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $10.14M $15.24M
YoY Change
Total Liabilities & Shareholders Equity $24.80M $30.67M
YoY Change 144.48%

Cashflow Statement

Concept 2018 Q4 2018 Q3 2017 Q3
OPERATING ACTIVITIES
Net Income -$6.411M -$4.926M $5.085M
YoY Change -208.3% -196.87%
Depreciation, Depletion And Amortization $150.0K $391.2K $240.6K
YoY Change -72.22% 62.65%
Cash From Operating Activities -$4.090M -$6.100M -$5.660M
YoY Change 45.55% 7.77%
INVESTING ACTIVITIES
Capital Expenditures -$10.00K -$130.0K -$280.0K
YoY Change -96.43% -53.57%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$10.00K -$130.0K -$280.0K
YoY Change -96.43% -53.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -30.00K 19.26M 2.900M
YoY Change -102.03% 564.14%
NET CHANGE
Cash From Operating Activities -4.090M -6.100M -5.660M
Cash From Investing Activities -10.00K -130.0K -280.0K
Cash From Financing Activities -30.00K 19.26M 2.900M
Net Change In Cash -4.130M 13.03M -3.040M
YoY Change 156.52% -528.62%
FREE CASH FLOW
Cash From Operating Activities -$4.090M -$6.100M -$5.660M
Capital Expenditures -$10.00K -$130.0K -$280.0K
Free Cash Flow -$4.080M -$5.970M -$5.380M
YoY Change 61.26% 10.97%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Registrant Name
EntityRegistrantName
Bionano Genomics, Inc.
dei Entity Central Index Key
EntityCentralIndexKey
0001411690
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2018-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Trading Symbol
TradingSymbol
BNGO
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2018Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10032687
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20657038
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1021897
CY2018Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4000924
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3352214
CY2018Q3 us-gaap Inventory Net
InventoryNet
2614812
CY2017Q4 us-gaap Inventory Net
InventoryNet
1693742
CY2018Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1347774
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1071512
CY2018Q3 us-gaap Assets Current
AssetsCurrent
28620548
CY2017Q4 us-gaap Assets Current
AssetsCurrent
7139365
CY2018Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2049256
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3005788
CY2018Q3 us-gaap Assets
Assets
30669804
CY2017Q4 us-gaap Assets
Assets
10145153
CY2018Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2363752
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2302964
CY2017Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
211697
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q3 bngo Preferred Stock Warrant Liability Current
PreferredStockWarrantLiabilityCurrent
0
CY2017Q4 bngo Preferred Stock Warrant Liability Current
PreferredStockWarrantLiabilityCurrent
3898944
CY2018Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
0
CY2017Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
6729752
CY2018Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2815290
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9551687
CY2018Q3 us-gaap Liabilities Current
LiabilitiesCurrent
5514646
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16652251
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3508894
CY2018Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
335604
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2018Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
9008337
CY2017Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
243160120
CY2018Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10032687
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
77257
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2505137
CY2018Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2967073
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6962696
CY2018Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
144602
CY2017Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
142929
CY2018Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
767197
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
567047
CY2018Q3 us-gaap Liabilities
Liabilities
15434782
CY2017Q4 us-gaap Liabilities
Liabilities
17362227
CY2018Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2018Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2018Q3 us-gaap Common Stock Value
CommonStockValue
1002
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
8
CY2018Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
81584992
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4038817
CY2018Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-66350972
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-54266036
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
15235022
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-50227211
CY2018Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
30669804
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10145153
CY2018Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10032687
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
77257
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2828704
CY2017Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2743056
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7987198
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6659920
CY2018Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3068332
CY2017Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1690223
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5723211
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4534340
CY2018Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3224075
CY2017Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3116922
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9617814
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10553348
CY2018Q3 us-gaap Costs And Expenses
CostsAndExpenses
5729212
CY2017Q3 us-gaap Costs And Expenses
CostsAndExpenses
6083995
us-gaap Profit Loss
ProfitLoss
-17445440
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1169801
us-gaap Costs And Expenses
CostsAndExpenses
16580510
us-gaap Costs And Expenses
CostsAndExpenses
20105035
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5968840
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5031162
us-gaap Operating Income Loss
OperatingIncomeLoss
-14316523
us-gaap Operating Income Loss
OperatingIncomeLoss
-17979455
CY2018Q3 us-gaap Interest Expense
InterestExpense
404437
CY2017Q3 us-gaap Interest Expense
InterestExpense
145308
us-gaap Interest Expense
InterestExpense
1114053
us-gaap Interest Expense
InterestExpense
431403
CY2018Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1520159
CY2017Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-154469
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3991081
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1108362
CY2018Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
75957
CY2017Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
68189
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
639137
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
125324
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1039765
CY2017Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-59028
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2237891
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
551635
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4929075
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5090190
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12078632
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17427820
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2978
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4738
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6304
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17620
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-4926097
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-5085452
us-gaap Net Income Loss
NetIncomeLoss
-12084936
us-gaap Net Income Loss
NetIncomeLoss
-17445440
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.63
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.74
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.99
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-6.68
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7778605
CY2017Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2920839
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6079285
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2609863
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
-27258972
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
14295
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
382830
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-23365364
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3499
bngo Adjustments To Additional Paid In Capital Reclassification Of Convertible Preferred Stock Warrant Liability
AdjustmentsToAdditionalPaidInCapitalReclassificationOfConvertiblePreferredStockWarrantLiability
84676
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
160551
us-gaap Profit Loss
ProfitLoss
-12084936
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
964932
us-gaap Share Based Compensation
ShareBasedCompensation
160551
us-gaap Share Based Compensation
ShareBasedCompensation
241971
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-262000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0
us-gaap Inventory Write Down
InventoryWriteDown
1287000
us-gaap Inventory Write Down
InventoryWriteDown
364437
bngo Accretion Of Debt Discount
AccretionOfDebtDiscount
-121984
bngo Accretion Of Debt Discount
AccretionOfDebtDiscount
-66241
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-342164
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
386710
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
692637
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2101453
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
442849
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
276263
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-241032
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
60788
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
320184
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
106476
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-518298
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15853679
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18008789
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
319885
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
736063
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-319885
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-736063
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
7447571
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0
us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
9532957
us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
0
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
14329843
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0
us-gaap Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants
ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants
0
us-gaap Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants
ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants
16131764
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
19389978
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3499
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1500
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
35808706
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16133264
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
19635142
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2611589
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1021897
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5249620
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
20657038
CY2017Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2633904
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
14898326
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0
bngo Conversion Of Preferred Stock Warrants Into Common Stock And Common Stock Warrants
ConversionOfPreferredStockWarrantsIntoCommonStockAndCommonStockWarrants
84676
bngo Conversion Of Preferred Stock Warrants Into Common Stock And Common Stock Warrants
ConversionOfPreferredStockWarrantsIntoCommonStockAndCommonStockWarrants
0
bngo Transfer Of Instruments To Property And Equipment From Inventory
TransferOfInstrumentsToPropertyAndEquipmentFromInventory
106617
bngo Transfer Of Instruments To Property And Equipment From Inventory
TransferOfInstrumentsToPropertyAndEquipmentFromInventory
0
bngo Fair Value Of Warrants Issued With Debt Classified As Liability
FairValueOfWarrantsIssuedWithDebtClassifiedAsLiability
176813
bngo Fair Value Of Warrants Issued With Debt Classified As Liability
FairValueOfWarrantsIssuedWithDebtClassifiedAsLiability
0
bngo Final Payment Fee Due In Connection With Repayment Of Debt Classified Within Other Long Term Liabilities
FinalPaymentFeeDueInConnectionWithRepaymentOfDebtClassifiedWithinOtherLongTermLiabilities
400000
bngo Final Payment Fee Due In Connection With Repayment Of Debt Classified Within Other Long Term Liabilities
FinalPaymentFeeDueInConnectionWithRepaymentOfDebtClassifiedWithinOtherLongTermLiabilities
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1275884
CY2018Q3 us-gaap Supplies
Supplies
249071
CY2017Q4 us-gaap Supplies
Supplies
492330
CY2018Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1098703
CY2018Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4430150
CY2017Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1275884
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4430150
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
On July 16, 2018, the Company effected a one-for-21.4 reverse stock split of its issued and outstanding shares of common stock and a proportional adjustment to the existing conversion ratios for each series of the Company’s redeemable convertible preferred stock, and on August 15, 2018, the Company effected an additional one-for-two reverse stock split of its issued and outstanding shares of common stock and a proportional adjustment to the existing conversion ratios for each series of the Company’s redeemable convertible preferred stock. Accordingly, all share and per share amounts for all periods presented in the accompanying financial statements and notes thereto have been adjusted retroactively, where applicable, to reflect these reverse stock splits and adjustments of the preferred stock conversion ratios.
CY2018Q3 bngo Reverse Stock Split Conversion Ratio
ReverseStockSplitConversionRatio
0.046
CY2018Q3 bngo Reverse Stock Split Conversion Ratio
ReverseStockSplitConversionRatio
0.5
CY2018Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
4000924
CY2017Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
3614214
CY2018Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
262000
CY2018Q3 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
242783
CY2017Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
203085
CY2018Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2372029
CY2017Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1490657
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2017Q4 us-gaap Other Assets Current
OtherAssetsCurrent
579182
CY2018Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7088141
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6927353
CY2018Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5038885
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3921565
CY2018Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
391246
CY2017Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
240551
CY2018Q3 bngo Accrued Expenses Current
AccruedExpensesCurrent
2185354
CY2017Q4 bngo Accrued Expenses Current
AccruedExpensesCurrent
2596137
CY2018Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
629936
CY2017Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
912757
CY2016Q1 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
113542
CY2016Q1 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0325
CY2018Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
0
CY2018Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
52194
CY2017Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
21558
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
121984
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
66241
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
53125
CY2017Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
24125
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
160551
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
241971
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.018
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.025
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.025
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.580
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.630
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.580
CY2017Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y3M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2018Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
132726
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y1M6D
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
0
CY2018Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
5689435
bngo Operating Lease Agreement Amended Date
OperatingLeaseAgreementAmendedDate
2015-07-01
us-gaap Lease Expiration Date1
LeaseExpirationDate1
2020-12-31
CY2018Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
147522
CY2017Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
147522
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
442566
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
442566
CY2018Q3 us-gaap Amortization Of Lease Incentives
AmortizationOfLeaseIncentives
56263
CY2017Q3 us-gaap Amortization Of Lease Incentives
AmortizationOfLeaseIncentives
56263
us-gaap Amortization Of Lease Incentives
AmortizationOfLeaseIncentives
168789
us-gaap Amortization Of Lease Incentives
AmortizationOfLeaseIncentives
168789
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
206721
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
862656
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
902412
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1971789
CY2018Q3 us-gaap Royalty Expense
RoyaltyExpense
76846
CY2017Q3 us-gaap Royalty Expense
RoyaltyExpense
75960
us-gaap Royalty Expense
RoyaltyExpense
295246
us-gaap Royalty Expense
RoyaltyExpense
235455
CY2017Q4 bngo Annual Future Minimum Royalty Payments
AnnualFutureMinimumRoyaltyPayments
70000
bngo Future Minimum Royalty Payments Extended Term
FutureMinimumRoyaltyPaymentsExtendedTerm
2026-11-29
CY2018Q3 us-gaap Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year
PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear
100000
CY2018Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0006
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0010
bngo Ownership Change In Series Of Transactions Period
OwnershipChangeInSeriesOfTransactionsPeriod
P3Y
bngo Minimum Percentage Of Change In Ownership
MinimumPercentageOfChangeInOwnership
0.50
us-gaap Defined Contribution Plan Plan Name
DefinedContributionPlanPlanName
401(k)
CY2018Q3 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
78020
CY2017Q3 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
97414
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
211185
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
334988

Files In Submission

Name View Source Status
0001564590-18-028130-index-headers.html Edgar Link pending
0001564590-18-028130-index.html Edgar Link pending
0001564590-18-028130.txt Edgar Link pending
0001564590-18-028130-xbrl.zip Edgar Link pending
bngo-10q_20180930.htm Edgar Link pending
bngo-20180930.xml Edgar Link completed
bngo-20180930.xsd Edgar Link pending
bngo-20180930_cal.xml Edgar Link unprocessable
bngo-20180930_def.xml Edgar Link unprocessable
bngo-20180930_lab.xml Edgar Link unprocessable
bngo-20180930_pre.xml Edgar Link unprocessable
bngo-ex311_8.htm Edgar Link pending
bngo-ex312_9.htm Edgar Link pending
bngo-ex321_7.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending